Quality of life with rivaroxaban in patients with non-valvular atrial fibrilation by therapeutic compliance.

Objective: To assess the quality of life (QOL) with rivaroxaban in patients with non-valvular atrial fibrilation (NVAF) related to therapeutic compliance.

Methods: Prospective, longitudinal, multicenter study was developed in 160 Spanish primary or specialized care centers. We included 412 patients treated with rivaroxaban, prescribed for stroke prevention.

Therapeutic compliance with rivaroxaban in preventing stroke in patients with non-valvular atrial fibrillation: CUMRIVAFA study.

Objective: To assess compliance with treatment with rivaroxaban in patients with non-valvular atrial fibrillation.

Methods: Prospective, longitudinal, multicenter study, developed in 160 Spanish primary or specialized care centers. We included 412 patients treated with rivaroxaban, prescribed for stroke prevention.

Evaluation of the relationship between effervescent paracetamol and blood pressure: clinical trial.

Background: Paracetamol's solubility is achieved by adding to the excipient sodium salts, either as bicarbonate, carbonate or citrate. As the relationship between salt and hypertension is well known, due to the sodium content it has raised a hypothesis that may interfere with the control of that risk factor. Therefore, the objective of this study is to evaluate the effect on blood pressure of effervescent paracetamol compared to non-effervescent, in hypertensive patients.

Non-compliance and inertia in hypertensive Spaniards at high cardiovascular risk: CUMPLE study.

Objective: To assess non-compliance (NC) and therapeutic inertia (TI) after 6 months of follow-up in hypertensive patients with poorly controlled blood pressure and high cardiovascular risk.

Research Design And Methods: Longitudinal, multicentre study; 3900 uncontrolled hypertensive patients were recruited from 585 primary healthcare centres. Tablets were counted during visits at baseline, 1, 3 and 6 months.

Do Patients With High Vascular Risk Take Antihypertensive Medication Correctly? Cumple-MEMS Study.

Introduction And Objectives: To assess compliance with treatment inhibit the renin-angiotensin system (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) in uncontrolled hypertension in patients at high cardiovascular risk.

Methods: Prospective, longitudinal, multicenter study, carried out in 102 Spanish primary care centers. We included 808 uncontrolled hypertensive patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers who were at high vascular risk; 4 visits were conducted: baseline and 1, 3, and 6 months later.

[The influence of correct blood pressure measurement on the diagnostic decisions in hypertensive patients. MEDIDA study].

Background And Objective: We aimed to assess the influence of correct blood pressure (BP) measurement, following the recommendations of the Spanish Guideline of Hypertension 2005 (SGH), on the diagnostic decisions in hypertensive patients.

Patients And Method: Prospective, longitudinal, observational, multicenter study conducted in hypertensive patients with stable pharmacologic therapy in primary care units. 4040 patients were included, in whom BP was measured following current clinical practice at the first visit (visit 1).

[Compliance with hypertension therapy in Spain, according to the views of family doctors. Complex project].

Objectives: To evaluate physicians' knowledge of therapy compliance, their attitudes towards it and their training needs in this field.

Design: Transversal, descriptive study using a questionnaire.

Setting: Primary care centres in Spain.

[Prevention of atrial fibrillation in hypertensive patients].

A large percentage of patients with hypertension suffer from atrial fibrillation (AF). The presence of hypertension increases the risk of AF, which in turn aggravates hypertension. The ability of drugs to interfere with specific signal transduction pathways easing the presence of AF in hypertensive patients is promising.

[Cardiovascular risk profile of uncontrolled hypertensive patients. The Control-Project study].

Background And Objective: To assess absolute cardiovascular risk and co-morbidities in uncontrolled hypertensive patients (blood pressure [BP]>or=140/90 mmHg or>or=130/80 mmHg in diabetics) attending Primary Care Physicians in Spain, and to determine the attitudes of these physicians towards this problem.

Patients And Method: Cross-sectional, multicenter study involving 356 general practitioners around Spain. Absolute cardiovascular risk was assessed according to ESH-ESC 2003 Guidelines in a sample of 1,710 patients.

[Analysis of studies published on hypertension treatment non-compliance in Spain between 1984 and 2005].

Objective: To analyse therapy non-compliance in hypertension treatment in Spain, after a review of studies published between 1984 and 2005.

Design: Systematic review.

Data Sources: Data searches used Internet (Medline and Spanish index on doctoral these), a manual search of several Spanish journals, and bibliographic references to compliance from detected articles and through personal contact with experts.

Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study.

Objective: To evaluate the efficacy of a programme of home blood pressure measurement (HBPM) on therapeutic compliance in mild-to-moderate hypertension.

Design: A prospective controlled multicentre clinical trial.

Setting: Forty primary care centres in Spain, with a duration of 6 months.

Efficacy of telephone and mail intervention in patient compliance with antihypertensive drugs in hypertension. ETECUM-HTA study.

Objective: To study the efficacy of telephone and mail intervention in therapeutic compliance among patients with mild to moderate hypertension.

Design: A prospective controlled multicenter clinical trial.

Setting: Eighty-five primary care centers in Spain, with a duration of 6 months.